Anticancer evaluation of new organometallic ruthenium( ii ) flavone complexes - RSC Medicinal Chemistry (RSC Publishing) DOI:10.1039/D2MD00304J
PDF) NAMI-A and KP1019/1339, Two Iconic Ruthenium Anticancer Drug Candidates Face-to-Face: A Case Story in Medicinal Inorganic Chemistry
Molecules | Free Full-Text | NAMI-A and KP1019/1339, Two Iconic Ruthenium Anticancer Drug Candidates Face-to-Face: A Case Story in Medicinal Inorganic Chemistry
NAMI Research Opportunity - Survey for adults with schizophrenia and/or their caregivers -
Chemical structure of NAMI-A, molecular weight 458.18 g/mol. | Download Scientific Diagram
The development of anticancer ruthenium(ii) complexes: from single molecule compounds to nanomaterials. | Semantic Scholar
Ruthenium(III) Complexes of NAMI-A Type with Ligands Based on Lonidamine and Bexarotene as Antiproliferative Agents | SpringerLink
Ruthenium(III) compounds in clinical trials KP1019 and NAMI-A. 2,3 | Download Scientific Diagram
NKP-1339, the first ruthenium-based anticancer drug on the edge to clinical application - Chemical Science (RSC Publishing) DOI:10.1039/C3SC53243G
COVID-19 Vaccine::NAMI
KP1019 - an overview | ScienceDirect Topics
NAMI New Jersey, N Brunswick, NJ
NAMI-A - Wikipedia
Molecular structure of the antimetastatic compound NAMI-A. | Download Scientific Diagram
Ru(III) complexes in clinical trials; NAMI-A and KP1019 | Download Scientific Diagram
Patient Centricity | Segal Trials
Chemical structures of NAMI-A, KP1019, and KP418. | Download Scientific Diagram
Ruthenium(III) compounds in clinical trials KP1019 and NAMI-A. 2,3 | Download Scientific Diagram
Taisa (Taya) Skubiak on LinkedIn: Schizophrenia clinical trial site staff interviews
Schematic structures of NAMI-A ((ImH)[trans-RuCl4(dmso-S)(Im)], Im =... | Download Scientific Diagram
Anticancer Research – The Gasser Group
Upcoming and Previous Events | Segal Trials
Mechanisms of reactions of Ru( iii )-based drug NAMI-A and its aquated products with DNA purine bases: a DFT study - RSC Advances (RSC Publishing) DOI:10.1039/C6RA24251K
NAMI-A | Cas# 201653-76-1 - GlpBio
